Amgen Inc.
Amgen Inc. logo
AMGN

Amgen Inc. (AMGN)

$286.41.56%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$279.025
Day's Range
$286.61
$192.56
52-Week Range
$294.64
1 month return5.27%
3 month return16.66%
1 year return42.63%
5 year return61.63%

Company Information

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
OrganizationAmgen Inc.
Employees24200
CEOMr. Robert A. Bradway
IndustryHealth Technology

Analyst Recommendation

based on 28 analysts ratings

Hold
32%
Buy
64%
Hold
3%
Sell

Based on 28 Wall street analysts offering stock ratings for Amgen Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Downside of 7.41%

Current

$286.4

Target

$265.19

Recommendation Trend

Based on 28 analyst

Current1M Ago3M Ago
Buy
9
14
15
Hold
18
19
19
Sell
1
2
2
Consensus
HOLD
HOLD
HOLD

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
150.5B
Book Value
$6.85
Dividend Share
7.58
Dividend Yield
2.8000000000000003%
Earnings Per Share (EPS)
12.46
PE Ratio
22.63
PEG Ratio
1.59
Wall Street Target Price
265.19

Valuation

Trailing PE22.63
Forward PE15.29
Price/Book (mrq)
41.44
Enterprise Value
178.6B
Enterprise Value/Revenue
6.78
Enterprise Value/Ebitda
14.39

Technicals

Beta
0.64
50 Day MA
258.52
200 Day MA
246.01

Sustainability

Rating Date2019-01-01
Total Esg
20.95
Total Esg Percentile
23.7
Environment Score1.53
Environment Score Percentile3.0
Social Score15.13
Social Score Percentile3.0
Governance Score5.8
GovernanceScorePercentile3.0
Controversy Level2.0

Institutional Holdings

Vanguard Group Inc

8.89%

State Street Corporation

5.45%

PRIMECAP Management Company

2.92%

Capital Research Global Investors

2.36%

Geode Capital Management, LLC

2.01%

Charles Schwab Investment Management Inc

1.73%

Discover more

Frequently Asked Questions

What is Amgen Inc. share price today?

Can Indians buy Amgen Inc. shares?

How can I buy Amgen Inc. shares from India?

Can Fractional shares of Amgen Inc. be purchased?

What are the documents required to start investing in Amgen Inc. stocks?

What are today’s High and Low prices of Amgen Inc.?

What are today’s traded volumes of Amgen Inc.?

What is today’s market capitalisation of Amgen Inc.?

What is the 52 Week High and Low Range of Amgen Inc.?

How much percentage Amgen Inc. is down from its 52 Week High?

How much percentage Amgen Inc. is up from its 52 Week low?

What are the historical returns of Amgen Inc.?

Who is the Chief Executive Officer (CEO) of Amgen Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*